Please use this identifier to cite or link to this item: http://hdl.handle.net/11452/24405
Full metadata record
DC FieldValueLanguage
dc.date.accessioned2022-02-10T11:11:51Z-
dc.date.available2022-02-10T11:11:51Z-
dc.date.issued2010-02-
dc.identifier.citationEvci, C. vd. (2010). "Comparative evaluation of the antifungal susceptibility of Candida isolates from blood specimens: Results of a study in a tertiary care hospital in Bursa, Turkey". Turkish Journal of Medical Sciences, 40(1), 141-149.tr_TR
dc.identifier.issn1300-0144-
dc.identifier.urihttps://doi.org/10.3906/sag-0808-14-
dc.identifier.urihttps://journals.tubitak.gov.tr/medical/issues/sag-10-40-1/sag-40-1-22-0808-14.pdf-
dc.identifier.urihttp://hdl.handle.net/11452/24405-
dc.description.abstractAim: Antifungal susceptibility testing may be an important aid in the treatment of patients with life threatening yeast infections. The aim of this study was to determine the susceptibility of Candida isolates obtained from clinical specimens to the antifungal agents amphotericin B and fluconazole, which are frequently used in our clinical practice. Materials and methods: Susceptibility to antifungal agents was investigated using the Etest (AB Biodisk, Solna, Sweden) and the reference broth macrodilution susceptibility test (CLSI M27-A2). The MICs obtained with each of the methods were read after 24 h and 48 h of incubation. Results: Overall agreement rates within +/- 1 dilution between the 2 methods were 86.7% (24 h) and 94.1% (48 h) for amphotericin B, and 85.5% (24 h) and 73.3% (48 h) for fluconazole. All C. albicans, C. pelliculosa, C. glabrata, and C. kefyr isolates were inhibited by <= 1 mu g mL-1 of amphotericin B, and fluconazole resistance was not observed in C. albicans or C. tropicalis isolates according to the 2 methods. Conclusion: According to the results of this study, decreased susceptibility to fluconazole and amphotericin B was most prominent in C. parapsilosis, C. krusei, and C. glabrata isolates.en_US
dc.description.abstractAmaç: Antifungal duyarlılık testleri, yaşamı tehdit eden maya mantarı enfeksiyonu olan hastaların tedavisinde büyük önem taşımaktadır. Bu çalışmanın amacı klinik örneklerden soyutlanan Candida kökenlerinin pratik uygulamada sıklıkla kullanılan antifungal ilaçlar olan amfoterisin B ve flukonazole duyarlılıklarının belirlenmesidir. Yöntem ve gereç: Antifungal ilaçlara duyarlılık, Etest (AB Biodisk, Solna, İsveç) ve referans broth makrodilüsyon duyarlılık testi (CLSI M27-A2) ile araştırıldı. MİK değerleri, her iki yöntem ile 24 ve 48 saatlik inkübasyonun sonunda değerlendirildi. Bulgular: İki yöntem arasında (±) 1 dilüsyon içinde uyum oranları, amfoterisin B için % 86,7 (24 saat) ve % 94,1 (48 saat), flukonazol için % 85,5 (24 saat) ve % 73,3 (48 saat) idi. C. albicans, C. pelliculosa, C. glabrata ve C. kefyr kökenlerinin tümü, ≤1 μg mL−1 konsantrasyonda amfoterisin B ile inhibe oldu ve C. albicans ya da C. tropicalis kökenlerinde her iki yöntem ile flukonazole direnç saptanmadı. Sonuç: Bu çalışmada, flukonazol ve amfoterisin B’ye duyarlılığın azalması, en belirgin olarak C. parapsilosis, C. krusei ve C. glabrata kökenlerinde görüldü.tr_TR
dc.language.isoenen_US
dc.publisherTÜBİTAKtr_TR
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.rightsAtıf Gayri Ticari Türetilemez 4.0 Uluslararasıtr_TR
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subjectCandida speciesen_US
dc.subjectAntifungal susceptibility testsen_US
dc.subjectAntimicrobial surveillance programen_US
dc.subjectAmphotericin-Ben_US
dc.subjectBroth microdilutionen_US
dc.subjectNational-committeeen_US
dc.subjectStream infectionsen_US
dc.subjectEtest methoden_US
dc.subjectFluconazoleen_US
dc.subjectVoriconazoleen_US
dc.subjectTrendsen_US
dc.subjectMacrodilutionen_US
dc.subjectGeneral & internal medicineen_US
dc.subjectAlbicansen_US
dc.subjectAntifungal agentsen_US
dc.subjectAntifungal susceptibilityen_US
dc.subjectAntifungal susceptibility testingen_US
dc.subjectBlood specimensen_US
dc.subjectCandida speciesen_US
dc.subjectClinical practicesen_US
dc.subjectComparative evaluationsen_US
dc.subjectFluconazoleen_US
dc.subjectKefyren_US
dc.subjectSusceptibility testsen_US
dc.subjectFungicidesen_US
dc.subjectCandida türleritr_TR
dc.subjectAntifungal duyarlılık testleritr_TR
dc.titleComparative evaluation of the antifungal susceptibility of Candida isolates from blood specimens: Results of a study in a tertiary care hospital in Bursa, Turkeyen_US
dc.typeArticleen_US
dc.identifier.wos000275833900022tr_TR
dc.identifier.scopus2-s2.0-76149105159tr_TR
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergitr_TR
dc.contributor.departmentUludağ Üniversitesi/Tıp Fakültesi/Tıbbi Mikrobiyoloji Anabilim Dalı.tr_TR
dc.contributor.orcid0000-0002-4803-8206tr_TR
dc.contributor.orcid0000-0002-4759-9634tr_TR
dc.identifier.startpage141tr_TR
dc.identifier.endpage149tr_TR
dc.identifier.volume40tr_TR
dc.identifier.issue1tr_TR
dc.relation.journalTurkish Journal of Medical Sciencesen_US
dc.contributor.buuauthorEvci, Canan-
dc.contributor.buuauthorEner, Beyza-
dc.contributor.buuauthorGöral, Güher-
dc.contributor.buuauthorAkçağlar, Sevim-
dc.contributor.researcheridAAG-8523-2021tr_TR
dc.indexed.trdizinTrdizintr_TR
dc.subject.wosMedicine, general & internalen_US
dc.indexed.wosSCIEen_US
dc.indexed.scopusScopusen_US
dc.wos.quartileQ4en_US
dc.contributor.scopusid22034011200tr_TR
dc.contributor.scopusid15053025300tr_TR
dc.contributor.scopusid6603453166tr_TR
dc.contributor.scopusid6506194958tr_TR
dc.subject.scopusCandidemia; Invasive Candidiasis; Candida Parapsilosisen_US
dc.subject.emtreeAmphotericin Ben_US
dc.subject.emtreeFluconazoleen_US
dc.subject.emtreeAntifungal resistanceen_US
dc.subject.emtreeAntifungal susceptibilityen_US
dc.subject.emtreeArticleen_US
dc.subject.emtreeBlood samplingen_US
dc.subject.emtreeBroth dilutionen_US
dc.subject.emtreeCandidaen_US
dc.subject.emtreeCandida albicansen_US
dc.subject.emtreeCandida glabrataen_US
dc.subject.emtreeCandida kruseien_US
dc.subject.emtreeCandida parapsilosisen_US
dc.subject.emtreeCandida tropicalisen_US
dc.subject.emtreeCandida zeylanoidesen_US
dc.subject.emtreeClinical evaluationen_US
dc.subject.emtreeClinical practiceen_US
dc.subject.emtreeComparative studyen_US
dc.subject.emtreeFungus cultureen_US
dc.subject.emtreeFungus isolationen_US
dc.subject.emtreeIncubation timeen_US
dc.subject.emtreeKluyveromyces marxianusen_US
dc.subject.emtreeMinimum inhibitory concentrationen_US
dc.subject.emtreeNonhumanen_US
dc.subject.emtreePichia anomalaen_US
dc.subject.emtreeTertiary health careen_US
dc.subject.emtreeTurkey (bird)en_US
Appears in Collections:Scopus
TrDizin
Web of Science

Files in This Item:
File Description SizeFormat 
Evci_vd_2010.pdf117.97 kBAdobe PDFThumbnail
View/Open


This item is licensed under a Creative Commons License Creative Commons